C. Walsh

Molecular Biology · Nature · 2000–2015

A researcher in the Science corpus: 18 papers; trusts 3 researchers and is trusted by 32 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 77 citations into it; #1,815 of 17,773 by trust here, #2,235 by citations
• Pharmacology — 25 citations into it; #26 of 1,112 by trust here, #41 by citations
• Organic Chemistry — 10 citations into it; #956 of 1,495 by trust here, #687 by citations
• Genetics — 9 citations into it; #6,726 of 6,854 by trust here, #1,966 by citations
• Biotechnology — 7 citations into it; #107 of 496 by trust here, #105 by citations

Whom C. Walsh trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Stefan Schreiber
2. A. Coates
3. Stephen R. Palumbi
4. G. Cragg
5. C. Pickart

Who trusts C. Walsh overall

1. Teddie Rahube
2. Kim Lewis
3. Michael A. Fischbach
4. Christopher K. Yost
5. M. Friedman
6. Michael A. Kohanski
7. Jon Clardy
8. B. Khameneh
9. Wenbo Yu
10. Sriram Chandrasekaran

Papers from C. Walsh's perspective

Ordered by how strongly the researchers C. Walsh trusts endorse each paper. Same corpus, a different order for every researcher.

1. Lessons from natural molecules (Nature)
2. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis (Science)
3. Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms. (Chemical Reviews)
4. Glycopeptide and lipoglycopeptide antibiotics. (Chemical Reviews)
5. Biosynthesis of Complex Polyketides in a Metabolically Engineered Strain of E. coli (Science)
6. Antibacterial natural products in medicinal chemistry--exodus or revival? (Angewandte Chemie)
7. Isolating "Uncultivable" Microorganisms in Pure Culture in a Simulated Natural Environment (Science)
8. Natural products as sources of new drugs over the period 1981-2002. (Journal of Natural Products)
9. The influence of natural products upon drug discovery. (Natural product reports (Print))
10. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae (Nature)

Their papers

• Glycopeptide and lipoglycopeptide antibiotics. (2005) — 597 citations
• Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. (2013) — 1,606 citations
• Molecular mechanisms that confer antibacterial drug resistance (2000) — 1,530 citations
• Protein posttranslational modifications: the chemistry of proteome diversifications. (2005) — 1,484 citations
• Opinion — anti-infectives: Where will new antibiotics come from? (2003) — 737 citations
• The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) (2002) — 1,762 citations
• Minimum Information about a Biosynthetic Gene cluster (2015) — 802 citations
• Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms. (2006) — 1,353 citations
• Antibiotics For Emerging Pathogens (2009) — 1,757 citations
• Genetics and Assembly Line Enzymology of Siderophore Biosynthesis in Bacteria (2002) — 779 citations
• Site-specific protein labeling by Sfp phosphopantetheinyl transferase (2006) — 309 citations
• The behavior and significance of slow-binding enzyme inhibitors. (2006) — 751 citations
• Non-heme Fe(IV)-oxo intermediates. (2007) — 796 citations
• New antibiotics from bacterial natural products (2006) — 601 citations
• Lessons from natural molecules (2004) — 1,069 citations
• Antibiotics: Actions, Origins, Resistance (2003) — 869 citations
• Chirality of peptide bond-forming condensation domains in Nonribosomal peptide synthetases: The C5 domain of tyrocidine synthetase is a DCL catalyst (2003) — 84 citations
• Formation of β-Hydroxy Histidine in the Biosynthesis of Nikkomycin Antibiotics (2002) — 124 citations